Cargando…

Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model

BACKGROUND: Treatment of head and neck cancer with radiation often results in damage to surrounding normal tissues such as salivary glands. Permanent loss of function in the salivary glands often leads patients to discontinue treatment due to incapacitating side effects. It has previously been shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Katie L., Hill, Grace A., Klein, Rob R., Arnett, Deborah G., Burd, Randy, Limesand, Kirsten H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517508/
https://www.ncbi.nlm.nih.gov/pubmed/23236487
http://dx.doi.org/10.1371/journal.pone.0051363
_version_ 1782252426147921920
author Martin, Katie L.
Hill, Grace A.
Klein, Rob R.
Arnett, Deborah G.
Burd, Randy
Limesand, Kirsten H.
author_facet Martin, Katie L.
Hill, Grace A.
Klein, Rob R.
Arnett, Deborah G.
Burd, Randy
Limesand, Kirsten H.
author_sort Martin, Katie L.
collection PubMed
description BACKGROUND: Treatment of head and neck cancer with radiation often results in damage to surrounding normal tissues such as salivary glands. Permanent loss of function in the salivary glands often leads patients to discontinue treatment due to incapacitating side effects. It has previously been shown that IGF-1 suppresses radiation-induced apoptosis and enhances G2/M arrest leading to preservation of salivary gland function. In an effort to recapitulate the effects of IGF-1, as well as increase the likelihood of translating these findings to the clinic, the small molecule therapeutic Roscovitine, is being tested. Roscovitine is a cyclin-dependent kinase inhibitor that acts to transiently inhibit cell cycle progression and allow for DNA repair in damaged tissues. METHODOLOGY/PRINCIPAL FINDINGS: Treatment with Roscovitine prior to irradiation induced a significant increase in the percentage of cells in the G(2)/M phase, as demonstrated by flow cytometry. In contrast, mice treated with radiation exhibit no differences in the percentage of cells in G(2)/M when compared to unirradiated controls. Similar to previous studies utilizing IGF-1, pretreatment with Roscovitine leads to a significant up-regulation of p21 expression and a significant decrease in the number of PCNA positive cells. Radiation treatment leads to a significant increase in activated caspase-3 positive salivary acinar cells, which is suppressed by pretreatment with Roscovitine. Administration of Roscovitine prior to targeted head and neck irradiation preserves normal tissue function in mouse parotid salivary glands, both acutely and chronically, as measured by salivary output. CONCLUSIONS/SIGNIFICANCE: These studies suggest that induction of transient G(2)/M cell cycle arrest by Roscovitine allows for suppression of apoptosis, thus preserving normal salivary function following targeted head and neck irradiation. This could have an important clinical impact by preventing the negative side effects of radiation therapy in surrounding normal tissues.
format Online
Article
Text
id pubmed-3517508
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35175082012-12-12 Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model Martin, Katie L. Hill, Grace A. Klein, Rob R. Arnett, Deborah G. Burd, Randy Limesand, Kirsten H. PLoS One Research Article BACKGROUND: Treatment of head and neck cancer with radiation often results in damage to surrounding normal tissues such as salivary glands. Permanent loss of function in the salivary glands often leads patients to discontinue treatment due to incapacitating side effects. It has previously been shown that IGF-1 suppresses radiation-induced apoptosis and enhances G2/M arrest leading to preservation of salivary gland function. In an effort to recapitulate the effects of IGF-1, as well as increase the likelihood of translating these findings to the clinic, the small molecule therapeutic Roscovitine, is being tested. Roscovitine is a cyclin-dependent kinase inhibitor that acts to transiently inhibit cell cycle progression and allow for DNA repair in damaged tissues. METHODOLOGY/PRINCIPAL FINDINGS: Treatment with Roscovitine prior to irradiation induced a significant increase in the percentage of cells in the G(2)/M phase, as demonstrated by flow cytometry. In contrast, mice treated with radiation exhibit no differences in the percentage of cells in G(2)/M when compared to unirradiated controls. Similar to previous studies utilizing IGF-1, pretreatment with Roscovitine leads to a significant up-regulation of p21 expression and a significant decrease in the number of PCNA positive cells. Radiation treatment leads to a significant increase in activated caspase-3 positive salivary acinar cells, which is suppressed by pretreatment with Roscovitine. Administration of Roscovitine prior to targeted head and neck irradiation preserves normal tissue function in mouse parotid salivary glands, both acutely and chronically, as measured by salivary output. CONCLUSIONS/SIGNIFICANCE: These studies suggest that induction of transient G(2)/M cell cycle arrest by Roscovitine allows for suppression of apoptosis, thus preserving normal salivary function following targeted head and neck irradiation. This could have an important clinical impact by preventing the negative side effects of radiation therapy in surrounding normal tissues. Public Library of Science 2012-12-07 /pmc/articles/PMC3517508/ /pubmed/23236487 http://dx.doi.org/10.1371/journal.pone.0051363 Text en © 2012 Martin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Martin, Katie L.
Hill, Grace A.
Klein, Rob R.
Arnett, Deborah G.
Burd, Randy
Limesand, Kirsten H.
Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title_full Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title_fullStr Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title_full_unstemmed Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title_short Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model
title_sort prevention of radiation-induced salivary gland dysfunction utilizing a cdk inhibitor in a mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517508/
https://www.ncbi.nlm.nih.gov/pubmed/23236487
http://dx.doi.org/10.1371/journal.pone.0051363
work_keys_str_mv AT martinkatiel preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel
AT hillgracea preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel
AT kleinrobr preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel
AT arnettdeborahg preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel
AT burdrandy preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel
AT limesandkirstenh preventionofradiationinducedsalivaryglanddysfunctionutilizingacdkinhibitorinamousemodel